He YC, Wang YH, Cao J, Chen JW, Pan DY, Zhou YK. Effect of complex amino acid imbalance on growth of tumor in tumor-bearing rats. World J Gastroenterol 2003; 9(12): 2772-2775 [PMID: 14669331 DOI: 10.3748/wjg.v9.i12.2772]
Corresponding Author of This Article
Dr. Yin-Cheng He, Department of General Surgery, Zhongnan Hospital, Wuhan University, Wuhan 430071, Hubei Province, China. w030508h@public.wh.hb.cn
Article-Type of This Article
Basic Research
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Yin-Cheng He, Jun Cao, Ji-Wei Chen, Ding-Yu Pan, Ya-Kui Zhou, Department of General Surgery, Zhongnan Hospital, Wuhan University, Wuhan 430071, Hubei Province, China
Yuan-Hong Wang, Wuhan Centre for Disease Prevention and Control, Wuhan 430022, Hubei Province, China
ORCID number: $[AuthorORCIDs]
Author contributions: All authors contributed equally to the work.
Supported by grants from Hubei Provincial Health Bureau, No. W98016 and the Education Committee of Hubei Province, No. 2001A14005
Correspondence to: Dr. Yin-Cheng He, Department of General Surgery, Zhongnan Hospital, Wuhan University, Wuhan 430071, Hubei Province, China. w030508h@public.wh.hb.cn
Telephone: +86-27-67812963
Received: June 5, 2003 Revised: June 18, 2003 Accepted: August 16, 2003 Published online: December 15, 2003
Abstract
AIM: To investigate the effect of complex amino acid imbalance on the growth of tumor in tumor-bearing (TB) rats.
METHODS: Sprague-Dawlley (SD) rats underwent jejunostomy for nutritional support. A suspension of Walker-256 carcinosarcoma cells was subcutaneously inoculated. TB rats were randomly divided into groups A, B, C and D according to the formula of amino acids in enteral nutritional solutions, respectively. TB rats received jejunal feedings supplemented with balanced amino acids (group A), methionine-depleted amino acids (group B), valine-depleted amino acids (group C) and methionine- and valine-depleted complex amino acid imbalance (group D) for 10 days. Tumor volume, inhibitory rates of tumor, cell cycle and life span of TB rats were investigated.
RESULTS: The G0/G1 ratio of tumor cells in group D (80.5 ± 9.0)% was higher than that in groups A, B and C which was 67.0% ± 5.1%, 78.9% ± 8.5%, 69.2% ± 6.2%, respectively (P < 0.05). The ratio of S/G2M and PI in group D were lower than those in groups A, B and C. The inhibitory rate of tumor in groups B, C and D was 37.2%, 33.3% and 43.9%, respectively (P < 0.05). The life span of TB rats in group D was significantly longer than that in groups B, C, and A.
CONCLUSION: Methionine/valine-depleted amino acid imbalance can inhibit tumor growth. Complex amino acids of methionine and valine depleted imbalance have stronger inhibitory effects on tumor growth.
Key Words: $[Keywords]
Citation: He YC, Wang YH, Cao J, Chen JW, Pan DY, Zhou YK. Effect of complex amino acid imbalance on growth of tumor in tumor-bearing rats. World J Gastroenterol 2003; 9(12): 2772-2775
Malnutrition is encountered everyday in cancer patients and is associated with severe protein-amino acid metabolic disorder, uncorrectable negative nitrogen balance and low immune function[1-6]. Enteral nutrition (EN) and parenteral nutrition (PN) are both safe and effective methods of administering nutrients in cancer patients[7-9]. But PN with amino acid balanced solutions may prompt tumor growth[10-12]. Based on Harper’s concept of amino acid imbalance, EN/TPN preparations with depleted or enriched specific amino acids produce tumor growth inhibition[13-18]. Previously, we found methionine/ valine-depleted (0), low tyrosine (0.5 g/L) and arginine-enriched (6 g/L) complex amino acid imbalance solutions were the most rational formula in tumor-bearing (TB) rats[19]. In this study, we aimed to investigate the effect of complex amino acid imbalance on the growth of tumor.
MATERIALS AND METHODS
Animals
SD rats weighing 170 ± 20 g were purchased from the Experimental Animal Center of Wuhan University (Wuhan, China) and fed with a stock rat diet ad libitum. The animals were maintained on a 12-hour light/12-hour dark cycle at ambient temperature of (23 ± 2) °C and housed for 7 days before the experiment.
Catheterization of jejunostomy
After fasted for 12 hours, the rats (n = 60) were anesthetized by intraperitoneal administration of 40 mg·kg-1 pentobarbital. They were then undergone catheterization during jejunostomy (day 0). A silicone rubber catheter with an internal diameter of 2 mm and an external diameter of 3 mm was inserted into the proximal jejunum. The catheter passed through a subcutaneous tunnel and emerged between the scapulae. The catheter was then mounted on a harness, passed through a protective coil, and connected to a swivel so that the animals could move without any restrictions in individual metabolic cages. The cannulation system consisted of a microinfusion pump, a swivel, rat-harness and a silicone-tube-jejunostomy. The rats were fasted for 48 hours after operation but were provided with water ad libitum, and then given normal rat diet.
Preparation of TB rats
Walker-256 carcinosarcoma cells were purchased from Chinese Center of Culture Preservation. On day 0, the rats were subcutaneously inoculated in the right flank with 107 tumor cells of approximately 0.1 ml of cell suspension.
Tumor weights and inhibitory rates of tumor
Tumors were palpable 7 days after transplantation. Measurements were made at the tumor site. The lengths of the major, minor axes and depth were measured with calipers. Growth of the tumor was evaluated every 3 days. Tumor volumes during experiments were calculated according to the following equation: V = LWDπ/6. Where V is the tumor volume (mm3), L is the length, W is the width and D is the depth of a solid tumor (mm). Inhibitory rates of tumor = (tumor volume of control group-tumor volume of experimental group)/tumor volume of control group × 100%.
Experimental groups and jejunal feeding
On day 8, 48 TB rats were randomly divided into four groups (12 rats per group) according to the solutions administered: an amino acid balance solution (group A), methionine-depleted amino acid solution (group B), valine-depleted amino acid solution (group C), and methionine and valine-depleted complex amino acid solution (group D). They were administered enteral nutritional solutions (jejunal feeding) for 10 days. During EN, the rats were individually housed in metabolic cages. The compositions of EN solution infused to each rat are summarized in Table 1.
Table 1 Compositions of amino acid solution (g·L-1).
Amino acids
Group A
Group B
Group C
Group D
Isoleucine
5.5
5.5
5.5
5.5
Leucine
7.5
7.5
7.5
7.5
Lysine
7.0
7.0
7.0
7.0
Methionine
6.0
—
6.0
—
Phenylalanine
4.0
4.0
4.0
4.0
Threonine
5.0
5.0
5.0
5.0
Tryptophan
1.5
1.5
1.5
1.5
Valine
6.0
6.0
—
—
Arginine
6.0
6.0
6.0
6.0
Histidine
3.0
3.0
3.0
3.0
Proline
4.0
4.0
4.0
4.0
Tyrosine
1.0
1.0
1.0
1.0
Alanine
20.0
20.0
20.0
20.0
Glycine
7.5
7.5
7.5
7.5
Aspartic acid
4.0
4.0
4.0
4.0
Total amino acid
88.0
82.0
82.0
76.0
Total nitrogen
14.1
13.1
13.1
12.2
Administration methods
TB rats received continuous jejunal tube infusion for nutritional support at a daily dose of 330 ml·kg-1, by means of a microinfusion pump (Sino-Swed Pharmaceutical Corp. Ltd. China). Non-protein calorie per day was approximately 1104 K J·kg-1. TB rats were not fed during the entire infusion experiment, however, they had free access to water.
Compositions of amino acid solutions
Table 1 lists the components of amino acid solution in four groups.
Compositions of EN solution
1000 ml EN solution was composed of 350 ml of amino acid preparation (Table 1) supplemented with 300 ml of 50% glucose, 100 ml of 20% Intralipid (Sino-Swed Pharmaceutical Corp. Ltd. China), 20 ml of Soluvit, 20 ml of Vitalipid, 20 ml of Addamel and 190 ml of 0.9% saline.
Specimen sampling
At the end of an administration period, 6 rats per group were respectively killed by cervical dislocation. The whole tumor was dissected and examined.
Cell cycle position measurement
Sections about 50 μm thick were cut from tumor tissues and washed 3 times in phosphate-buffered saline. Cell kinetics were measured by flow cytometry (FCM, PASIII, Partec Company, Germany).
Life span of TB rats
The remaining 6 rats per group were given solid food (Experimental Animal Center of Wuhan University, Wuhan, China) and water ad libitum according to their body weight until they died of advanced cancer. The life span of each rat in terms of median survival time (MST) was observed.
Statistical analysis
All results were presented as mean ± SD. Comparisons of the four groups were made using Uni-variate ANOVA test. The difference was considered significant when P value was less than 0.05.
RESULTS
Animals
Two rats in groups A, C and two rats in group D died of intestinal fistula, diarrhea, infection of abdominal cavity during enteral nutrition, respectively.
Changes in tumor cell cycle
Tumor-selective cell cycle arrest occurred in the S-G2 phase during methionine depleted enteral nutrition. The distribution of cancer cell cycle was not obviously affected during valine starvation. The percentages of tumor cells in G0G1 phase in groups B and D were significantly higher than that in group A while the percentages of S phase cells in groups B and D were obviously lower than that in group A (P < 0.05). There was no statistical difference between the percentages of G2M cells in groups B and D and that in group A (P > 0.05, Table 2).
Table 2 Distribution of cancer cell cycle after EN treatment (%).
Tumor volume had no statistical difference among each group before treatment. On day 10 of enteral nutrition, tumor growth in amino acid imbalance groups (groups B, C and D) was significantly lower than that in control group. The most remarkable inhibitory effect on tumor growth was found in complex amino acid imbalance group (group D) (P < 0.05). The inhibitory rate of tumor (IRT) in groups B, C and D was respectively 37.2%, 33.3% and 43.9% (Table 3).
Table 3 Changes in tumor volumes, IRT and MST before and after treatment.
The median survival time (MST) in complex amino acid imbalance group was (39.4 ± 3.0) days, as compared with (32.0 ± 2.6) days in methionine-depleted group and (35.6 ± 3.2) days in valine-depleted group (Table 3).
DISCUSSION
Influence of balanced amino acids on tumor growth
Compared with normal cells, the metabolism of tumor cells is significantly accelerated. In vivo, cancer cells have been known to have higher levels of protein synthesis, accompanied by a more active uptake of glucose and amino acids (nitrogen trap), and undergo more rapid differentiation and proliferation than healthy cells[20]. Amino acids are important materials of protein synthesis, Supplement of balanced amino acids results in the greatest increase of tumor cell cycles, thus tumor tissues compete with host tissues for nitrogen substrates. Nucleic acid and protein synthesis are increased, and tumor growth is accelerated. Table 3 indicates the experimental results of the anticancer effects of various amino acid imbalance solutions. As clearly shown in this table, tumor volume was especially large, and the median survival time was short after TB rats were administrated with balanced amino acid solutions (group A).
Influence of methionine/valine-depleted amino acid imbalance on tumor growth
Methionine dependency of many malignant tumor cells has been demonstrated in previous studies. That is to say, these cells were arrested in late S/G2 phase in methionine free cell culture media, and tumor cellular proliferation was inhibited, and normal cells were methionine independent after methionine was replaced by hemocysteine[21-26]. Methionine is the principal biological methyl donor via S-adenosyl-L-methionine (SAM). SAM can easily transfer its methyl group to a large variety of acceptor substrates including rRNA, tRNA, mRNA, DNA, proteins, phospholipides, biological amines, and a long list of small molecules. Methionine dependency might be due to overutilization of methionine for transmethylation reactions resulting in a low free methionine pool and a low S-adenosylmethionie/S-adenosylhomocysteine ratio[27-31]. This directly inhibits the activity of transmethylase, thereby methionine depleted enteral nutrition can decrease methylation reaction of tumor tissues and lead to further reduction in nucleic acid synthesis and inhibition of cancer growth at molecular levels.
Our study demonstrated that tumor growth in group B was significantly slower than that in control group, the liver and peritoneum metastasis of cancer was much less in group B. It suggested that the invasive ability for metastasis be suppressed during methionine starvation. Breillout et al considered that methionine depletion disturbed the membrane lipids of tumor cells and inhibited their metastatic ability[32].
It was also found that valine depleted imbalance solution (group C) had a great inhibitory effect on Walker-256 carcinosarcoma cells. One possible mechanism was the alterations of intracellular protein synthesis due to deprivation of essential amino acids (Valine)[33-35]. Another possible mechanism seemed to be the inhibitory effect on the production of prolactin, which was likely to participate in tumor growth[20].
Influence of complex amino acid imbalance on tumor growth
As shown in Table 3, the most remarkable inhibitory effect on cancer growth was seen in the methionine/valine depleted complex amino acid imbalance group, followed by the methionine depleted imbalance group and then the valine depleted group. It suggested that complex amino acid imbalance solutions had the most strong anticancer effects. However, are we able to prevent the development of side effects of complex imbalance due to starvation of essential amino acids This still needs further studies.
Xiao HB, Cao WX, Yin HR, Lin YZ, Ye SH. Influence of L-methionine-deprived total parenteral nutrition with 5-fluorouracil on gastric cancer and host metabolism.World J Gastroenterol. 2001;7:698-701.
[PubMed] [DOI][Cited in This Article: ]
Karayiannakis AJ, Syrigos KN, Polychronidis A, Pitiakoudis M, Bounovas A, Simopoulos K. Serum levels of tumor necrosis factor-alpha and nutritional status in pancreatic cancer patients.Anticancer Res. 2001;21:1355-1358.
[PubMed] [DOI][Cited in This Article: ]
Buchman AL. Enteral versus parenteral nutrition following resection in malnourished patients with gastrointestinal cancer.Curr Gastroenterol Rep. 2002;4:322-323.
[PubMed] [DOI][Cited in This Article: ]
Bozzetti F, Gavazzi C, Cozzaglio L, Costa A, Spinelli P, Viola G. Total parenteral nutrition and tumor growth in malnourished patients with gastric cancer.Tumori. 1999;85:163-166.
[PubMed] [DOI][Cited in This Article: ]
Cao WX, Cheng QM, Fei XF, Li SF, Yin HR, Lin YZ. A study of preoperative methionine-depleting parenteral nutrition plus chemotherapy in gastric cancer patients.World J Gastroenterol. 2000;6:255-258.
[PubMed] [DOI][Cited in This Article: ]
Nagahama T, Goseki N, Endo M. Doxorubicin and vincristine with methionine depletion contributed to survival in the Yoshida sarcoma bearing rats.Anticancer Res. 1998;18:25-31.
[PubMed] [DOI][Cited in This Article: ]
Tang B, Li YN, Kruger WD. Defects in methylthioadenosine phosphorylase are associated with but not responsible for methionine-dependent tumor cell growth.Cancer Res. 2000;60:5543-5547.
[PubMed] [DOI][Cited in This Article: ]
Yoshida S, Ohta J, Shirouzu Y, Ishibashi N, Harada Y, Yamana H, Shirouzu K. Effect of methionine-free total parenteral nutrition and insulin-like growth factor I on tumor growth in rats.Am J Physiol. 1997;273:E10-E16.
[PubMed] [DOI][Cited in This Article: ]
Chen JW, He YC, Wang YH, Zhou YK, Liu QY, Shi HA. Rational formula of amino acids for nutritional supports in tumor-bear-ing rats.Zhonghua Shiyan Waike Zazhi. 2001;18:378.
[PubMed] [DOI][Cited in This Article: ]
Hoshiya Y, Kubota T, Inada T, Kitajima M, Hoffman RM. Methionine-depletion modulates the efficacy of 5-fluorouracil in human gastric cancer in nude mice..Anticancer Res. 1997;17:4371-4375.
[PubMed] [DOI][Cited in This Article: ]
Poirson-Bichat F, Gonçalves RA, Miccoli L, Dutrillaux B, Poupon MF. Methionine depletion enhances the antitumoral efficacy of cytotoxic agents in drug-resistant human tumor xenografts.Clin Cancer Res. 2000;6:643-653.
[PubMed] [DOI][Cited in This Article: ]
Poirson-Bichat F, Lopez R, Bras Gonçalves RA, Miccoli L, Bourgeois Y, Demerseman P, Poisson M, Dutrillaux B, Poupon MF. Methionine deprivation and methionine analogs inhibit cell proliferation and growth of human xenografted gliomas.Life Sci. 1997;60:919-931.
[PubMed] [DOI][Cited in This Article: ][Cited by in Crossref: 21][Cited by in F6Publishing: 24][Article Influence: 0.9][Reference Citation Analysis (0)]
Sasamura T, Matsuda A, Kokuba Y. Effects of D-methionine-containing solution on tumor cell growth in vitro.Arzneimittelforschung. 1999;49:541-543.
[PubMed] [DOI][Cited in This Article: ]
Cao WX, Ou JM, Fei XF, Zhu ZG, Yin HR, Yan M, Lin YZ. Methionine-dependence and combination chemotherapy on human gastric cancer cells in vitro.World J Gastroenterol. 2002;8:230-232.
[PubMed] [DOI][Cited in This Article: ]
Zhu SS, Xiao SD, Chen ZP, Shi Y, Fang JY, Li RR, Mason JB. DNA methylation and folate metabolism in gastric cancer.World J Gastroenterol. 2000;6:18.
[PubMed] [DOI][Cited in This Article: ]
Yoshioka T, Wada T, Uchida N, Maki H, Yoshida H, Ide N, Kasai H, Hojo K, Shono K, Maekawa R. Anticancer efficacy in vivo and in vitro, synergy with 5-fluorouracil, and safety of recombinant methioninase.Cancer Res. 1998;58:2583-2587.
[PubMed] [DOI][Cited in This Article: ]
Samuels SE, Knowles AL, Tilignac T, Debiton E, Madelmont JC, Attaix D. Protein metabolism in the small intestine during cancer cachexia and chemotherapy in mice.Cancer Res. 2000;60:4968-4974.
[PubMed] [DOI][Cited in This Article: ]
He YC, Cao J, Chen JW, Pan DY, Zhou YK. Influence of methionine/valine-depleted enteral nutrition on nucleic acid and protein metabolism in tumor-bearing rats.World J Gastroenterol. 2003;9:771-774.
[PubMed] [DOI][Cited in This Article: ]